TOKYO and NEW YORK; May 8, 2013 – Accenture (NYSE: ACN) has signed an eight-year application outsourcing agreement with Astellas Pharma Inc. (TSE:4503, “Astellas”). As part of the contract, Accenture will deliver application development and maintenance services to the leading pharmaceutical company, which researches, develops and manufactures prescription drugs.